JenaValve Technology, Inc.
JenaValve Technology is a medical device company developing minimally invasive heart valve treatments for aortic regurgitation and stenosis. The company has raised $342M, most recently in a Series C round in August 2022, and employs 244 people. Its Trilogy Heart Valve System is the only device approved in the EU for treating severe aortic regurgitation in high-risk patients.
The growth story
JenaValve Technology, Inc. grew from 122 to 244 employees between 2021 and 2026, raising $342M along the way, most recently a Series C in August 2022.
About
JenaValve makes transcatheter heart valve systems designed for minimally invasive treatment of aortic regurgitation and stenosis. Its Trilogy System is CE-mark approved in the EU for both conditions and is undergoing clinical trials in the US for aortic regurgitation, with enrollment completed for the ALIGN-AR IDE trial.
The company has raised $342M, including a Series C round in 2022, and employs 244 people. Its Trilogy System is notable as the first and only device approved in the EU for treating severe aortic regurgitation in high-risk patients, positioning it as a potential leader in this niche market.
Founders and leadership
Engineering is the largest function at JenaValve, accounting for 26% of analyzed profiles. The company is led by a team with deep experience in medical devices, though specific leadership details are not provided.
The JenaValve Technology, Inc. org chart
John Kilcoyne (CEO) leads 59 mapped leaders with 10 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Quality Assurance 34 (+26% YoY), Research 30 (+7% YoY), Engineering 29 (+12% YoY), Operations 29 (+12% YoY), Sales 15 (+150% YoY), Information Technology 13 (+86% YoY).
Talent flow
JenaValve draws heavily from major medical device companies, with Edwards Lifesciences (32 hires), Medtronic (24), and Abbott (15) being the top talent sources. Alumni frequently move to Edwards Lifesciences (9 departures) and Terumo Neuro (4). The median tenure is 2 years, suggesting moderate turnover.
Most common previous employers of JenaValve Technology, Inc. staff: Edwards Lifesciences (32), Medtronic (24), Abbott (15), Boston Scientific (15), St. Jude Medical (10), Endologix (7). Former JenaValve Technology, Inc. employees most often moved to Edwards Lifesciences (9), Terumo Neuro (4), Emboline (3), AbbVie (3), JenaValve Technology (3), Boston Scientific (2).
Alumni worth knowing
The JenaValve Technology, Inc. mafia
JenaValve alumni have founded 5 companies, including Vebego Deutschland, which employs 114 people, and Akilia Partners, which has 3 staff. Other ventures include CD4 Therapeutics, Management & Consulting, and Cortechs Designs.
5Ramon Maas, was Director of Service Operations EMEA until 2013Jose (Pepe) Calle Gordo, was Board Member until 2024Stephan Wehselau, was CFO - Geschäftsführer until 2015Pieter Van den Steen, was Chief Commercial Officer and Managing Director JenaValve Technology GmbH until 2017John Nguyen, was Sr. R&D Engineer until 2014Hiring now
Web traffic
Traffic mix: 36% direct, 58% search, 0% social, 0% paid.
What this company is made of
Most common skills at JenaValve Technology, Inc.: Medical Devices (94), Microsoft Office (72), Leadership (63), Microsoft Excel (59), Customer Service (47), Management (46), Project Management (45), Microsoft Word (42).
Where the team actually sits
JenaValve Technology, Inc. people are concentrated in California, United States (69), England, United Kingdom (19), United States (9), Los Angeles Metropolitan Area (6).
Search footprint
JenaValve Technology, Inc. attracts about 168 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 35 ranking keywords and lost 46 in the last period.
What employees say
- Compensation
- 3.00 / 5
- Career opportunities
- 2.50 / 5
- Senior management
- 2.30 / 5
- Work-life balance
- 2.80 / 5
Frequently asked
JenaValve Technology, Inc. has 244 employees as of September 2026.
JenaValve Technology, Inc. has raised $342M in total, most recently a Series C round in August 2022.
John Kilcoyne (CEO) sits at the top of JenaValve Technology, Inc.'s reporting structure, with 10 direct reports.
The most common previous employers of current JenaValve Technology, Inc. staff are Edwards Lifesciences (32 people), Medtronic (24 people), Abbott (15 people).
Former JenaValve Technology, Inc. employees most often move to Edwards Lifesciences (9), Terumo Neuro (4), Emboline (3).
At least 5 companies have a founder who previously worked at JenaValve Technology, Inc., including Vebego Deutschland, Akilia Partners, CD4 Therapeutics.
JenaValve Technology, Inc. attracts about 168 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among JenaValve Technology, Inc. staff are Medical Devices, Microsoft Office, Leadership, Microsoft Excel, Customer Service.
JenaValve Technology, Inc. staff are concentrated in California, United States (69), England, United Kingdom (19), United States (9).
JenaValve Technology, Inc. has about 34 people in Quality Assurance, up 26% over the past year, as of September 2026.
JenaValve Technology, Inc. has about 30 people in Research, up 7% over the past year, as of September 2026.
Computed from 148 current and 166 former JenaValve Technology, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.